Effect of YiqiHuoxueHuatanTongluo formula on restenosis after vertebral artery stenting: A multicenter randomized control trial

China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1 Patients undergoing stent therapy within 14 days because of symptomatic severe vertebral artery stenosis (=70% stenosis as confirmed by DSA) had postoperative residual stenosis <20%, without serious perioperative complications
•2 Patients with qi deficiency and blood stasis and phlegm
•3 Age is 30-80 years, with no pregnancy planner within 6 months
•4 Patients and/or family members signed the informed consent

•1 Patients with severe heart, liver and kidney diseases, coagulation dysfunction and malignant tumors
•2 People with a history of allergy or serious adverse reactions to the test drug and its accessories
•3 Patients with gastrointestinal ulcer cannot be tolerated with double antiplatelet therapy
•4 Pregnancy, breastfeeding women or pregnancy plan recently
•5 Unable to take the medicine according to the prescribed dose and course of treatment
•6 Use of other TCM for the treatment of cerebrovascular diseases
•7 Patients who have participated in other drug clinical trials within 3 months
•8 Other circumstances not unsuitable to participate in this trial by the investigator

发起方